According to a market report by Lucintel, the future of the global diabetic neuropathy market looks promising with opportunities in the online pharmacy, hospital pharmacy, and retail pharmacy markets. The global diabetic neuropathy market is expected to grow with a CAGR of 5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of diabetes worldwide, the rising awareness about neuropathic disorders, and the growing demand for effective pain management.
A more
than 150-page report to understand trends, opportunity and forecast in global diabetic
neuropathy market to 2031 by type (oral, subcutaneous, and intravenous),
application (online pharmacies, hospital pharmacies, and retail pharmacies),
and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, subcutaneous is expected to witness
the highest growth over the forecast period.
Within the
application category, online pharmacy is expected to witness the highest growth.
Download
sample by clicking on diabetic
neuropathy market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Pfizer,
Janssen Pharmaceuticals, Eli Lilly and Company, ACTAVIS, Cephalon, MEDA Pharma,
GlaxoSmithKline, NeuroMetrix, Johnson & Johnson Services, Novartis are the
major suppliers in the diabetic
neuropathy market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
No comments:
Post a Comment